Are we losing the fight against malaria one more time?

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects  K. Ekelund, P. Skinhøj, J. Madsen, H.B.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
O. Clerc, G. Greub  Clinical Microbiology and Infection 
Refugee crisis and re-emergence of forgotten infections in Europe
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Nocardiosis in Quebec, Canada, 1988–2008
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
Training for the infectious diseases speciality in Norway
R. Karakus, K. Caglar, C. Aybay  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Metagenomics and probiotics
Hepatitis B and C virus-related carcinogenesis
U. Sagel, R.T. Mikolajczyk, A. Krämer 
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
Systematic review of antibiotic consumption in acute care hospitals
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
The role of antimalarial treatment in the elimination of malaria
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Benchmarking inappropriate empirical antibiotic treatment
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Clinical Microbiology and Infection
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
O. Clerc, G. Greub  Clinical Microbiology and Infection 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Influence of climate change on the incidence and impact of arenavirus diseases: a speculative assessment  J.C. Clegg  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Are we losing the fight against malaria one more time? M. Paul  Clinical Microbiology and Infection  Volume 17, Issue 11, Pages 1593-1596 (November 2011) DOI: 10.1111/j.1469-0691.2011.03666.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Bed-net coverage (left axis) and incidence of new malaria cases and death (right axis) in sub-Saharan Africa. Data obtained from the yearly Millennium Development Goals Report [18]. Clinical Microbiology and Infection 2011 17, 1593-1596DOI: (10.1111/j.1469-0691.2011.03666.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions